Aggregated
31% success rate- Bullish
- 11
- Hold
- 0
- Bearish
- 0
BTIG
A BTIG analyst with 14 tracked ratings across 13 distinct tickers has a 30.8% success rate on the captured sample, with recent ratings issued in two covered sectors.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| MGNX | 2024-08-01 | hold | - | Aggregated |
| GMAB | 2024-06-27 | buy | $47.00 | Aggregated |
| GMABGENMAB - ADR | 2024-06-27 | unknown | $47.00 | Aggregated |
| MGNX | 2024-05-24 | buy | $9.00 | Aggregated |
| CGEM | 2024-04-17 | buy | $30.00 | Aggregated |
| CGEMCULLINAN THERAPEUTICS INC | 2024-04-17 | unknown | $30.00 | Aggregated |
| XNCR | 2024-04-16 | buy | $38.00 | Aggregated |
| XNCRXENCOR INC | 2024-04-16 | unknown | $38.00 | Aggregated |
| NUVB | 2024-03-26 | buy | $5.00 | Aggregated |
| NUVBNUVATION BIO INC - ORDINARY SHARES - CLASS A | 2024-03-26 | unknown | $5.00 | Aggregated |
| MGNX | 2024-03-04 | buy | $24.00 | Aggregated |
| MGNXMACROGENICS INC | 2024-03-04 | unknown | $24.00 | Aggregated |
| PYXS | 2024-02-09 | buy | $8.00 | Aggregated |
| PYXSPYXIS ONCOLOGY INC | 2024-02-09 | unknown | $8.00 | Aggregated |
| EXEL | 2023-12-19 | buy | $27.00 | Aggregated |
| EXELEXELIXIS INC | 2023-12-19 | unknown | $27.00 | Aggregated |
| RCUS | 2023-08-23 | buy | $70.00 | Aggregated |
| RCUSARCUS BIOSCIENCES INC | 2023-08-23 | unknown | $70.00 | Aggregated |
| STTK | 2022-08-31 | buy | $12.00 | Aggregated |
| STTKSHATTUCK LABS INC | 2022-08-31 | unknown | $12.00 | Aggregated |
| ONCT | 2022-02-24 | buy | $5.00 | Aggregated |
| ONCTONCTERNAL THERAPEUTICS INC | 2022-02-24 | unknown | $5.00 | Aggregated |
| SONN | 2022-02-09 | buy | $2.00 | Aggregated |
| SONNSONNET BIOTHERAPEUTICS HOLDINGS INC | 2022-02-09 | unknown | $2.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| MGNX | 4 | 2024-08-01 | Aggregated |
| GMAB | 2 | 2024-06-27 | Aggregated |
| GMABGENMAB - ADR | 1 | 2024-06-27 | Aggregated |
| CGEM | 2 | 2024-04-17 | Aggregated |
| CGEMCULLINAN THERAPEUTICS INC | 1 | 2024-04-17 | Aggregated |
| XNCR | 2 | 2024-04-16 | Aggregated |
| XNCRXENCOR INC | 1 | 2024-04-16 | Aggregated |
| NUVB | 2 | 2024-03-26 | Aggregated |
| NUVBNUVATION BIO INC - ORDINARY SHARES - CLASS A | 1 | 2024-03-26 | Aggregated |
| MGNXMACROGENICS INC | 1 | 2024-03-04 | Aggregated |
| PYXS | 3 | 2024-02-09 | Aggregated |
| PYXSPYXIS ONCOLOGY INC | 1 | 2024-02-09 | Aggregated |
| EXEL | 2 | 2023-12-19 | Aggregated |
| EXELEXELIXIS INC | 1 | 2023-12-19 | Aggregated |
| RCUS | 2 | 2023-08-23 | Aggregated |
| RCUSARCUS BIOSCIENCES INC | 1 | 2023-08-23 | Aggregated |
| STTK | 2 | 2022-08-31 | Aggregated |
| STTKSHATTUCK LABS INC | 1 | 2022-08-31 | Aggregated |
| ONCT | 2 | 2022-02-24 | Aggregated |
| ONCTONCTERNAL THERAPEUTICS INC | 1 | 2022-02-24 | Aggregated |
| SONN | 2 | 2022-02-09 | Aggregated |
| SONNSONNET BIOTHERAPEUTICS HOLDINGS INC | 1 | 2022-02-09 | Aggregated |